The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AbCellera Biologics Inc. | COM | 00288U106 | 209,422 | 10,450,180 | SH | SOLE | 10,450,180 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 696,137 | 41,910,704 | SH | SOLE | 41,910,704 | 0 | 0 | ||
Acceleron Pharma Inc. | COM | 00434H108 | 3,860 | 22,430 | SH | SOLE | 22,430 | 0 | 0 | ||
Achilles Therapeutics plc | SPONSORED ADS | 00449L102 | 20,187 | 2,591,366 | SH | SOLE | 2,591,366 | 0 | 0 | ||
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 50,826 | 9,830,877 | SH | SOLE | 9,830,877 | 0 | 0 | ||
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 27,110 | 3,410,106 | SH | SOLE | 3,410,106 | 0 | 0 | ||
Aerovate Therapeutics, Inc. | COM | 008064107 | 34,663 | 1,652,171 | SH | SOLE | 1,652,171 | 0 | 0 | ||
Affimed N.V. | COM | N01045108 | 1,017 | 164,605 | SH | SOLE | 164,605 | 0 | 0 | ||
Akero Therapeutics, Inc. | COM | 00973Y108 | 2,646 | 118,378 | SH | SOLE | 118,378 | 0 | 0 | ||
Albireo Pharma, Inc. | COM | 01345P106 | 12,869 | 412,466 | SH | SOLE | 412,466 | 0 | 0 | ||
Alector, Inc. | COM | 014442107 | 5,459 | 239,228 | SH | SOLE | 239,228 | 0 | 0 | ||
Aligos Therapeutics, Inc. | COM | 01626L105 | 32,205 | 2,076,400 | SH | SOLE | 2,076,400 | 0 | 0 | ||
Alkermes plc | SHS | G01767105 | 37,877 | 1,228,170 | SH | SOLE | 1,228,170 | 0 | 0 | ||
Allakos Inc. | COM | 01671P100 | 74,432 | 703,050 | SH | SOLE | 703,050 | 0 | 0 | ||
Altimmune, Inc. | COM | 02155H200 | 12,125 | 1,072,038 | SH | SOLE | 1,072,038 | 0 | 0 | ||
Amarin Corporation plc | SPONSORED ADR | 023111206 | 111,466 | 21,856,032 | SH | SOLE | 21,856,032 | 0 | 0 | ||
Amryt Pharma plc | SPONSORED ADR | 03217L106 | 6,244 | 518,380 | SH | SOLE | 518,380 | 0 | 0 | ||
AnaptysBio, Inc. | COM | 032724106 | 11,585 | 427,179 | SH | SOLE | 427,179 | 0 | 0 | ||
argenx SE | SPONSORED ADR | 04016X101 | 338,106 | 1,119,557 | SH | SOLE | 1,119,557 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 723,886 | 4,541,604 | SH | SOLE | 4,541,604 | 0 | 0 | ||
Athira Pharma, Inc. | COM | 04746L104 | 7,564 | 806,367 | SH | SOLE | 806,367 | 0 | 0 | ||
Atreca, Inc. | CL A COM | 04965G109 | 22,009 | 3,532,760 | SH | SOLE | 3,532,760 | 0 | 0 | ||
aTyr Pharma, Inc. | COM | 002120202 | 5,675 | 625,000 | SH | SOLE | 625,000 | 0 | 0 | ||
Aurinia Pharmaceuticals Inc. | COM | 05156V102 | 11,519 | 520,523 | SH | SOLE | 520,523 | 0 | 0 | ||
Axsome Therapeutics, Inc. | COM | 05464T104 | 17,767 | 539,057 | SH | SOLE | 539,057 | 0 | 0 | ||
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 4,235,810 | 11,668,897 | SH | SOLE | 11,668,897 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | COM | 079481404 | 727 | 249,123 | SH | SOLE | 249,123 | 0 | 0 | ||
BioAtla, Inc. | COM | 09077B104 | 24,288 | 825,000 | SH | SOLE | 825,000 | 0 | 0 | ||
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 182,654 | 12,710,818 | SH | SOLE | 12,710,818 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 588,988 | 7,620,494 | SH | SOLE | 7,620,494 | 0 | 0 | ||
Biomea Fusion, Inc. | COM | 09077A106 | 6,280 | 524,617 | SH | SOLE | 524,617 | 0 | 0 | ||
bluebird bio, Inc. | COM | 09609G100 | 47,770 | 2,499,715 | SH | SOLE | 2,499,715 | 0 | 0 | ||
Burning Rock Biotech Limited | SPONSORED ADS | 12233L107 | 3,739 | 209,131 | SH | SOLE | 209,131 | 0 | 0 | ||
Cabaletta Bio, Inc. | COM | 12674W109 | 8,051 | 662,063 | SH | SOLE | 662,063 | 0 | 0 | ||
Centessa Pharmaceuticals plc | SPONSORED ADS | 152309100 | 18,825 | 1,127,273 | SH | SOLE | 1,127,273 | 0 | 0 | ||
Cerus Corporation | COM | 157085101 | 83,513 | 13,713,195 | SH | SOLE | 13,713,195 | 0 | 0 | ||
ChemoCentryx, Inc. | COM | 16383L106 | 5,150 | 301,195 | SH | SOLE | 301,195 | 0 | 0 | ||
Chinook Therapeutics, Inc. | COM | 16961L106 | 24,283 | 1,903,069 | SH | SOLE | 1,903,069 | 0 | 0 | ||
Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 19,380 | 920,656 | SH | SOLE | 920,656 | 0 | 0 | ||
Cymabay Therapeutics, Inc. | COM | 23257D103 | 7,922 | 2,170,464 | SH | SOLE | 2,170,464 | 0 | 0 | ||
Cyteir Therapeutics, Inc. | COM | 23284P103 | 14,262 | 812,640 | SH | SOLE | 812,640 | 0 | 0 | ||
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 71,610 | 14,614,264 | SH | SOLE | 14,614,264 | 0 | 0 | ||
Denali Therapeutics Inc. | COM | 24823R105 | 4,477 | 88,738 | SH | SOLE | 88,738 | 0 | 0 | ||
Design Therapeutics, Inc. | COM | 25056L103 | 21,104 | 1,436,636 | SH | SOLE | 1,436,636 | 0 | 0 | ||
DICE Therapeutics, Inc. | COM | 23345J104 | 19,265 | 588,235 | SH | SOLE | 588,235 | 0 | 0 | ||
Edgewise Therapeutics, Inc. | COM | 28036F105 | 8,300 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
Evofem Biosciences, Inc. | COM | 30048L104 | 1,992 | 2,697,110 | SH | SOLE | 2,697,110 | 0 | 0 | ||
Forma Therapeutics Holdings, Inc. | SHS | 34633R104 | 46,957 | 2,024,876 | SH | SOLE | 2,024,876 | 0 | 0 | ||
Fulgent Genetics, Inc. | COM | 359664109 | 36,071 | 401,016 | SH | SOLE | 401,016 | 0 | 0 | ||
Gamida Cell Ltd. | SHS | M47364100 | 2,394 | 610,626 | SH | SOLE | 610,626 | 0 | 0 | ||
Genetron Holdings Limited | ADS | 37186H100 | 6,306 | 455,306 | SH | SOLE | 455,306 | 0 | 0 | ||
Global Blood Therapeutics, Inc. | COM | 37890U108 | 81,980 | 3,217,441 | SH | SOLE | 3,217,441 | 0 | 0 | ||
Harmony Biosciences Holdings, Inc. | COM | 413197104 | 4,738 | 123,600 | SH | SOLE | 123,600 | 0 | 0 | ||
Heron Therapeutics, Inc. | COM | 427746102 | 86,928 | 8,131,678 | SH | SOLE | 8,131,678 | 0 | 0 | ||
HOOKIPA Pharma Inc. | COM | 43906K100 | 4,126 | 700,481 | SH | SOLE | 700,481 | 0 | 0 | ||
Horizon Therapeutics Public Ltd Co | SHS | G46188101 | 65,627 | 599,110 | SH | SOLE | 599,110 | 0 | 0 | ||
IGM Biosciences, Inc. | COM | 449585108 | 207,545 | 3,156,102 | SH | SOLE | 3,156,102 | 0 | 0 | ||
Immatics N.V. | SHS | N44445109 | 57,509 | 4,423,731 | SH | SOLE | 4,423,731 | 0 | 0 | ||
Immunocore Holdings plc | ADS | 45258D105 | 93,443 | 2,520,730 | SH | SOLE | 2,520,730 | 0 | 0 | ||
Incyte Corporation | COM | 45337C102 | 2,202,482 | 32,022,125 | SH | SOLE | 32,022,125 | 0 | 0 | ||
Inozyme Pharma, Inc. | COM | 45790W108 | 1,240 | 106,999 | SH | SOLE | 106,999 | 0 | 0 | ||
Insmed Incorporated | COM PAR $.01 | 457669307 | 59,376 | 2,156,001 | SH | SOLE | 2,156,001 | 0 | 0 | ||
Instil Bio, Inc. | COM | 45783C101 | 69,600 | 3,893,700 | SH | SOLE | 3,893,700 | 0 | 0 | ||
Invitae Corporation | COM | 46185L103 | 280,703 | 9,873,488 | SH | SOLE | 9,873,488 | 0 | 0 | ||
Iteos Therapeutics, Inc. | COM | 46565G104 | 4,059 | 150,346 | SH | SOLE | 150,346 | 0 | 0 | ||
Karuna Therapeutics, Inc. | COM | 48576A100 | 8,559 | 69,966 | SH | SOLE | 69,966 | 0 | 0 | ||
Kezar Life Sciences, Inc. | COM | 49372L100 | 1,207 | 139,676 | SH | SOLE | 139,676 | 0 | 0 | ||
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 31,887 | 2,799,577 | SH | SOLE | 2,799,577 | 0 | 0 | ||
Kodiak Sciences Inc. | COM | 50015M109 | 1,409,112 | 14,681,304 | SH | SOLE | 14,681,304 | 0 | 0 | ||
Krystal Biotech, Inc. | COM | 501147102 | 31,730 | 607,735 | SH | SOLE | 607,735 | 0 | 0 | ||
Kura Oncology, Inc. | COM | 50127T109 | 5,697 | 304,158 | SH | SOLE | 304,158 | 0 | 0 | ||
Kymera Therapeutics, Inc. | COM | 501575104 | 140,080 | 2,384,742 | SH | SOLE | 2,384,742 | 0 | 0 | ||
Leap Therapeutics, Inc. | COM | 52187K101 | 2,244 | 559,705 | SH | SOLE | 559,705 | 0 | 0 | ||
Legend Biotech Corporation | SPONSORED ADS | 52490G102 | 119,524 | 2,364,003 | SH | SOLE | 2,364,003 | 0 | 0 | ||
LogicBio Therapeutics, Inc. | COM | 54142F102 | 2,068 | 451,478 | SH | SOLE | 451,478 | 0 | 0 | ||
MacroGenics, Inc. | COM | 556099109 | 9,268 | 442,579 | SH | SOLE | 442,579 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 119,622 | 1,499,213 | SH | SOLE | 1,499,213 | 0 | 0 | ||
Mereo BioPharma Group plc | ADS | 589492107 | 708 | 292,692 | SH | SOLE | 292,692 | 0 | 0 | ||
Merus N.V. | COM | N5749R100 | 44,824 | 2,037,469 | SH | SOLE | 2,037,469 | 0 | 0 | ||
Mirati Therapeutics, Inc. | COM | 60468T105 | 249,405 | 1,409,784 | SH | SOLE | 1,409,784 | 0 | 0 | ||
Mirum Pharmaceuticals, Inc. | COM | 604749101 | 12,894 | 647,313 | SH | SOLE | 647,313 | 0 | 0 | ||
Neoleukin Therapeutics, Inc. | COM | 64049K104 | 27,631 | 3,821,740 | SH | SOLE | 3,821,740 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | COM | 64125C109 | 64,929 | 676,975 | SH | SOLE | 676,975 | 0 | 0 | ||
NexImmune, Inc. | COM | 65344D109 | 4,453 | 294,117 | SH | SOLE | 294,117 | 0 | 0 | ||
NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 6,134 | 291,801 | SH | SOLE | 291,801 | 0 | 0 | ||
Novavax, Inc. | COM | 670002401 | 22,546 | 108,756 | SH | SOLE | 108,756 | 0 | 0 | ||
Nurix Therapeutics, Inc. | COM | 67080M103 | 73,524 | 2,454,082 | SH | SOLE | 2,454,082 | 0 | 0 | ||
Opthea Limited | SPONSORED ADS | 68386J208 | 27,062 | 3,382,797 | SH | SOLE | 3,382,797 | 0 | 0 | ||
Otonomy, Inc. | COM | 68906L105 | 14,773 | 7,694,038 | SH | SOLE | 7,694,038 | 0 | 0 | ||
Oyster Point Pharma, Inc. | COM | 69242L106 | 728 | 61,424 | SH | SOLE | 61,424 | 0 | 0 | ||
Pacific Biosciences of California, Inc. | COM | 69404D108 | 139,119 | 5,444,963 | SH | SOLE | 5,444,963 | 0 | 0 | ||
Passage Bio, Inc. | COM | 702712100 | 1,167 | 117,161 | SH | SOLE | 117,161 | 0 | 0 | ||
Prelude Therapeutics Inc. | COM | 74065P101 | 316,370 | 10,123,824 | SH | SOLE | 10,123,824 | 0 | 0 | ||
Protara Therapeutics, Inc. | COM STK | 74365U107 | 1,382 | 199,671 | SH | SOLE | 199,671 | 0 | 0 | ||
Reata Pharmaceuticals, Inc. | CL A | 75615P103 | 22,534 | 223,976 | SH | SOLE | 223,976 | 0 | 0 | ||
Relmada Therapeutics, Inc. | COM | 75955J402 | 5,268 | 200,996 | SH | SOLE | 200,996 | 0 | 0 | ||
Replimune Group, Inc. | COM | 76029N106 | 4,550 | 153,512 | SH | SOLE | 153,512 | 0 | 0 | ||
Revolution Medicines, Inc. | COM | 76155X100 | 6,113 | 222,222 | SH | SOLE | 222,222 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 50,454 | 3,863,239 | SH | SOLE | 3,863,239 | 0 | 0 | ||
Seagen Inc. | COM | 81181C104 | 8,029,546 | 47,288,259 | SH | SOLE | 47,288,259 | 0 | 0 | ||
Sera Prognostics, Inc. | CLASS A COM | 81749D107 | 2,239 | 201,562 | SH | SOLE | 201,562 | 0 | 0 | ||
Surrozen, Inc. | COM | 86889P109 | 17,700 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
Surrozen, Inc. | W EXP 8/11/2026 | 86889P117 | 950 | 833,333 | SH | SOLE | 833,333 | 0 | 0 | ||
Syndax Pharmaceuticals, Inc. | COM | 87164F105 | 2,116 | 110,729 | SH | SOLE | 110,729 | 0 | 0 | ||
Talis Biomedical Corporation | COM | 87424L108 | 47,343 | 7,574,835 | SH | SOLE | 7,574,835 | 0 | 0 | ||
Tango Therapeutics, Inc. | COM | 87583X109 | 9,698 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
TCR2 Therapeutics Inc. | COM | 87808K106 | 1,502 | 176,461 | SH | SOLE | 176,461 | 0 | 0 | ||
Travere Therapeutics, Inc. | COM | 89422G107 | 49,464 | 2,039,772 | SH | SOLE | 2,039,772 | 0 | 0 | ||
Tricida, Inc. | COM | 89610F101 | 4,814 | 1,037,432 | SH | SOLE | 1,037,432 | 0 | 0 | ||
Tscan Therapeutics, Inc. | COM | 89854M101 | 11,885 | 1,425,000 | SH | SOLE | 1,425,000 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 40,084 | 444,444 | SH | SOLE | 444,444 | 0 | 0 | ||
Verastem, Inc. | COM | 92337C104 | 66,194 | 21,491,630 | SH | SOLE | 21,491,630 | 0 | 0 | ||
Verve Therapeutics, Inc. | COM | 92539P101 | 66,577 | 1,416,530 | SH | SOLE | 1,416,530 | 0 | 0 | ||
Vincerx Pharma, Inc. | COM | 92731L106 | 3,903 | 241,379 | SH | SOLE | 241,379 | 0 | 0 | ||
Xenon Pharmaceuticals Inc. | COM | 98420N105 | 11,485 | 751,639 | SH | SOLE | 751,639 | 0 | 0 | ||
Zymeworks Inc. | COM | 98985W102 | 49,614 | 1,708,472 | SH | SOLE | 1,708,472 | 0 | 0 | ||
Apellis Pharmaceuticals, Inc. | Note 3.5% 9/15/2026 | 03753UAB2 | 57,262 | 46,754,000 | PRN | SOLE | 46,754,000 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Note 0.599% 8/1/2024 | 09061GAH4 | 4,611 | 4,500,000 | PRN | SOLE | 4,500,000 | 0 | 0 | ||
Insmed Incorporated | Note 0.75% 6/1/2028 | 457669AB5 | 43,839 | 40,000,000 | PRN | SOLE | 40,000,000 | 0 | 0 | ||
Invitae Corporation | Note 2.0% 9/1/2024 | 46185LAB9 | 12,570 | 10,300,000 | PRN | SOLE | 10,300,000 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | DBCV 1.5% 11/15/2024 | 803607AB6 | 43,167 | 29,174,000 | PRN | SOLE | 29,174,000 | 0 | 0 | ||
Tricida, Inc. | Note 3.5% 5/15/2027 | 89610FAB7 | 31,375 | 75,000,000 | PRN | SOLE | 75,000,000 | 0 | 0 |